Clinical Trial

Hungarian National Systemic Amyloidosis Registry

Name: Hungarian National Systemic Amyloidosis Registry — clinical trial record (NCT07689331)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: AMYREG

Recruiting

View on ClinicalTrials.gov →

Summary

This registry is an observational, multicenter, retrospective and prospective, non-pharmacological study designed to collect and analyze data from patients with systemic amyloidosis treated in inpatient and outpatient cardiology, hematology, nephrology, and neurology departments across Hungary. The registry was established in 2025.

Trial Details

NCT Number	NCT07689331
Lead Sponsor	Semmelweis University
Conditions	Systemic Amyloidosis, ATTR Amyloidosis, AL Amyloidosis, Amyloid Cardiomyopathy
Enrollment	300 participants
Start Date	2026-03-08
Primary Completion	2028-05 (estimated)
Study Completion	2028-05 (estimated)
Updated on ClinicalTrials.gov	2026-07-08